Sort
39,280 grants matching “leukemia”
The role of the MBD2-NuRD complex in gamma-globin gene silencing
$656,634Gordon D Ginder · Virginia Commonwealth University · R01 · FY2022 · DK
The role of the MBD2-NuRD complex in gamma-globin gene silencing
$656,634Gordon D Ginder · Virginia Commonwealth University · R01 · FY2021 · DK
The role of the MBD2-NuRD complex in gamma-globin gene silencing
$656,634Gordon D Ginder · Virginia Commonwealth University · R01 · FY2019 · DK
The role of the MBD2-NuRD complex in gamma-globin gene silencing
$656,634Gordon D Ginder · Virginia Commonwealth University · R01 · FY2020 · DK
Identifying Multi-Level Predictors and Outcomes of Oral Anticancer Medication Adherence Initiation and Persistence among Patients with Hematologic Malignancies
$656,560Sarah M. Belcher · University Of Pittsburgh At Pittsburgh · R01 · FY2024 · CA
Studies in the Pathogenesis of Systemic Capillary Leak Syndrome
$656,390Kirk Druey · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI
Psychosocial Risk in Young Survivors of Early Onset Pediatric Cancer: The Role of Physical and Neurocognitive Late Effects
$656,362Cynthia A Gerhardt · Research Inst Nationwide Children'S Hosp · R01 · FY2024 · CA
Exploiting the VISTA Pathway to Prevent Acute GVHD and Control Steroid Refractory Disease
$656,304Bruce R. Blazar · University Of Minnesota · R01 · FY2024 · HL
Regulation of FLT3 Signaling in Leukemia
$656,275Wei Tong · Children'S Hosp Of Philadelphia · R01 · FY2023 · CA
Molecular Kits and Software for Lymphoid Malignancy Work-ups
$656,240David Scott Johnson · Gigagen, Inc. · R44 · FY2014 · CA
Quantitative Volume and Density Response Assessment: Sarcoma and HCC as a Model
$656,025Lawrence H Schwartz · Columbia University Health Sciences · U01 · FY2011 · CA
Neurodevelopmental Effects of Cannabis and its Epigenetic Regulation
$656,003Yasmin L Hurd · Icahn School Of Medicine At Mount Sinai · R01 · FY2020 · DA
Neurodevelopmental Effects of Cannabis and its Epigenetic Regulation
$656,003Yasmin L Hurd · Icahn School Of Medicine At Mount Sinai · R01 · FY2019 · DA
Enhancing Innate Immune Reconstitution Post Allogeneic HSCT.
$655,949Jonathan Stuart Serody · Univ Of North Carolina Chapel Hill · R01 · FY2022 · HL
Enhancing Innate Immune Reconstitution Post Allogeneic HSCT.
$655,949Jonathan Stuart Serody · Univ Of North Carolina Chapel Hill · R01 · FY2021 · HL
Congenital cytomegalovirus infection, KIR genotypes, and acute lymphoblastic leukemia
$655,862Logan G Spector · University Of Minnesota · R01 · FY2018 · CA
Novel strategies to understand, predict, and prevent vascular toxicity of targeted CML therapies
$655,590Iris Z Jaffe · Tufts Medical Center · R01 · FY2022 · HL
Graft-versus-Host Disease: Local Maintenance in Target Tissues by Tissue Resident Memory-Type Cells.
$655,553Warren D Shlomchik · University Of Pittsburgh At Pittsburgh · R01 · FY2019 · HL
Mechanisms of Intercellular Heme Homeostasis in Liver
$655,405Makiko Yasuda · Icahn School Of Medicine At Mount Sinai · R01 · FY2023 · DK
Stem Cells, Differentiation and Therapeutic Resistance in AML
$655,318Martin Carroll · University Of Pennsylvania · R01 · FY2011 · CA
Targeting minimal residual disease in AML by using single-cell morphological and biophysical analysis with deep learning
$655,219Scott R Manalis · Massachusetts Institute Of Technology · U01 · FY2025 · CA
Personal tumor neoantigens for immunity against chronic lymphocytic leukemia
$655,040Catherine Ju-Ying Wu · Dana-Farber Cancer Inst · R01 · FY2019 · CA
A118G SNP and OPRM1 Gene Opioid-Mediated Effects in Humans
$655,032Kelly E Dunn · Johns Hopkins University · R01 · FY2017 · DA
EPIGENETIC PLASTICITY IN PEDIATRIC PRE-B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
$654,999The Johns Hopkins University · · FY2021 · Department of the Army
Treatment of Leukocyte Adhesion Deficiency by Foamy Virus Vectors
$654,926David W Russell · University Of Washington · R01 · FY2014 · HL